Middle East and Africa Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)

Code: TIPRE00025453 | Pages: 116 | Industry: Pharmaceuticals | Date: Oct 2021 | Type: Regional

Market Introduction

Middle East & Africa consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia and South Africa, and Rest of Middle East and African region. The market is driven by the factors such as increasing government initiatives, growing domestic production for pharmaceutical products, and rising business expansion by international players. Saudi Arabia is among the largest economies in the Middle East region. Country's economy is most flourishing, which is supported by the diversified initiatives and increasing population. The growing demand for generic production and increasing international players' expansions into the country have provided substantial growth for the pharmaceutical industry. Additionally, the country-based companies have initiated importing raw materials for producing a generic version of the foreign-made branded medicines. Some of the country's leading manufacturers include Al Jazeera Pharmaceutical Industries, AJA Pharma, Banaja Saudi Import Company, Saudi Arabian Japanese Pharmaceutical Company (SAJA), Saudi Pharmaceutical Industries (SPI), SPIMACO, Tabuk Pharmaceuticals, and Al Jazeera Pharmaceutical Industries. Increasing adoption of AI-based tools for drug discovery is the major factor driving the growth of the MEA pharmaceutical intermediates market.

Countries in the Middle East have also widely affected the socio-economic condition by the COVID–19 pandemic. However, the countries have wisely reacted to the COVID–19 pandemic to avoid the spread of infection. COVID-19 infections are rising in Iraq, with 932,899 reported cases as of April, 2021. There have been 14,757 deaths due to coronavirus reported in the country since the pandemic began. Similarly, COVID-19 infections are growing in Jordan, with 4,266 new infections reported on an average each day. As of April 2021, there have been 669,300 infections and 7,855 coronavirus-related deaths in Jordan since the COVID pandemic began. Thus, the number of coronavirus cases are increasing in the region. The Middle East and Africa region include countries such as South Africa, the UAE, and Saudi Arabia. These countries have also registered a significant number of positive coronavirus infection cases. These regions are developing in terms of the pharmaceutical industry. The countries in these regions are highly dependent on pharmaceutical products imported from developed countries. Therefore, countries have faced several challenges for their requirements during the pandemic. The lockdown has affected the supply chain of various companies in these regions. However, as the crisis continues and government relaxations on the import of the pharmaceutical intermediates products are expected to witness significant growth in the number of orders.  However, as per the pharmacists in Riyadh, there is increased demand for nutritional supplements in Saudi Arabia since the outbreak of coronavirus in Saudi Arabia. The Health Ministry is coordinating with pharmacies to limit the quantity of nutritional supplements. Only one pack per customer should be sold in order to prevent the shortage for such items. This is likely to favor the growth of the pharmaceutical intermediates market.


Get more information on this report :



Market Overview and Dynamics

The pharmaceutical intermediates market in MEA is expected to grow from US$ 1,591.62 million in 2021 to US$ 1,972.66 million by 2028; it is estimated to grow at a CAGR of 3.1% from 2021 to 2028. Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.

Key Market Segments

The MEA pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in MEA are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; and Sanofi are among others.

Reasons to buy report

  • To understand the MEA pharmaceutical intermediates market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA pharmaceutical intermediates market
  • Efficiently plan M&A and partnership deals in MEA pharmaceutical intermediates market by identifying market segments with the most promising probable sales  
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA pharmaceutical intermediates market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.

MEA Pharmaceutical Intermediates Market Segmentation

MEA Pharmaceutical Intermediates Market -By Type

  • GMP
  • Non GMP

MEA Pharmaceutical Intermediates Market -By Application

  • Antibiotics
  • Antipyretic analgesics
  • Vitamins
  • Others

MEA Pharmaceutical Intermediates Market -By Distribution Channel

  • Distributor
  • Direct Sales

MEA Pharmaceutical Intermediates Market -By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA

MEA Pharmaceutical Intermediates Market -Company Profiles

  • BASF SE
  • chiracon GmbH
  • Codexis
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Sanofi

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Pharmaceutical Intermediates Market – By Type

1.3.2        MEA Pharmaceutical Intermediates Market – By Application

1.3.3        MEA Pharmaceutical Intermediates Market – By Distribution Channel

1.3.4        MEA Pharmaceutical Intermediates Market– By Country

2.           MEA Pharmaceutical Intermediates Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Pharmaceutical Intermediates Market– Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Expert Opinion

5.           MEA Pharmaceutical Intermediates Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Diseases and Infectious Diseases

5.1.2        Escalating R&D Investments by Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Cost of Manufacturing

5.3         Market Opportunities

5.3.1        Emerging Markets

5.4         Future Trends

5.4.1        Increasing Adoption of AI-based Tools for Drug Discovery

5.5         Impact Analysis

6.           Pharmaceutical Intermediates Market– MEA Analysis

6.1         MEA Pharmaceutical Intermediates Market Revenue Forecast and Analysis

7.           MEA Pharmaceutical Intermediates Market Analysis – By Type

7.1         Overview

7.2         Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

7.3         GMP

7.3.1        Overview

7.3.2        GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Non GMP

7.4.1        Overview

7.4.2        Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.           MEA Pharmaceutical Intermediates Market Analysis – By Application

8.1         Overview

8.2         Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

8.3         Antibiotics

8.3.1        Overview

8.3.2        Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Antipyretic Analgesics

8.4.1        Overview

8.4.2        Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Vitamins

8.5.1        Overview

8.5.2        Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Other

8.6.1        Overview

8.6.2        Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.           MEA Pharmaceutical Intermediates Market– By Distribution Channel

9.1         Overview

9.2         Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

9.3         Distributor

9.3.1        Overview

9.3.2        Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Direct Sales

9.4.1        Overview

9.4.2        Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

10.        MEA Pharmaceutical Intermediates Market – Country Analysis

10.1.1     Overview

10.1.2     Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.1.3     Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1       Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2       Saudi Arabia: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.3.3       Saudi Arabia: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.3.4       Saudi Arabia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.4     UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1       UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2       UAE: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.4.3       UAE: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.4.4       UAE: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.5     South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1       South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2       South Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.5.3       South Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.5.4       South Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6     Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1       Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2       Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.6.3       Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.6.4       Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on MEA Pharmaceutical Intermediates Market

11.1      Overview

12.        MEA Pharmaceutical Intermediates Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Pfizer Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Sanofi

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BASF SE

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dishman Carbogen Amcis Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Codexis

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Midas Pharma GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      chiracon GmbH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             MEA Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 5.             UAE Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             UAE Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             South Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done By Companies

Table 15.          Inorganic Developments Done By Companies

Table 16.          Glossary of Terms, Pharmaceutical Intermediates Market

LIST OF FIGURES

Figure 1.           MEA Pharmaceutical Intermediates Market Segmentation

Figure 2.           MEA Pharmaceutical Intermediates Segmentation, By Country

Figure 3.           MEA Pharmaceutical Intermediates Market Overview

Figure 4.           GMP Held Largest Share of Type Segment in MEA Pharmaceutical Intermediates Market

Figure 5.           Saudi Arabia to Show Remarkable Growth During Forecast Period

Figure 6.           MEA: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           MEA Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints

Figure 9.           MEA Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        MEA Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

Figure 11.        MEA GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        MEA Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

Figure 14.        MEA Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        MEA Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

Figure 19.        MEA Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Middle East and Africa: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 22.        Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 23.        Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Impact of COVID-19 Pandemic in Middle East and Africa Market

 

  1. BASF SE
  2. chiracon GmbH
  3. Codexis
  4. Dishman Carbogen Amcis Ltd
  5. Midas Pharma GmbH
  6. Pfizer Inc.
  7. Sanofi
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000